Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia...
-
Upload
gabriel-bond -
Category
Documents
-
view
213 -
download
0
Transcript of Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia...
![Page 1: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/1.jpg)
Carol Burke, MD, FACG, FASGE, AGAF, FACPSanford R Weiss Center for Hereditary Colorectal NeoplasiaDepartment of Gastroenterology and HepatologyCleveland Clinic, Cleveland, OhioSeptember 19, 2015
New Era of Genetic Testing in Colon Cancer
![Page 2: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/2.jpg)
Overview
• Recognize clues suggestive of a genetic colorectal cancer syndrome
• Understand the genetic testing process for hereditary colorectal cancer syndromes
![Page 3: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/3.jpg)
Pathways to CRC
AdenomaAdenoma SessileSessile Serrated Polyp Serrated Polyp
Sporadic CRC
CIN-MSS CIMPCIN-MSS CIMP
MSI MSIMSI MSI
MLH1 promotor methylation BRAF mutation
Lynch Syndrome
FAP MAP
![Page 4: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/4.jpg)
Chromosomal Instability
Pino MS, et al. NEJM 2010;339;1277
![Page 5: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/5.jpg)
CpG Island Methylation (CIMP)
Gene Expression
Gene Silencing
Turns off MLH1
![Page 6: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/6.jpg)
Multi Target Stool DNA Testing vs FIT • Assay: Methylation of BMP3 and NDRG4, KRAS mutations ,
B-actin and a fecal immunochemical test
Imperiale T, 2014;370:1287
P < 0.001%
P < 0.001P = 0.002
![Page 7: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/7.jpg)
Microsatellite Instability
• Repeated nucleotide sequences called “microsatellites”
• DNA fidelity maintained by Mismatch Repair Proteins (MMR)
Boland CR, Gastroenterology 2010;138:2073
MLH1 PMS2
MSH2 MSH6
![Page 8: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/8.jpg)
Mismatch Repair Protein Function
Nucleotide
mismatch
Normal MMR
Defective MMR Etiology: 1.MLH1 promoter methylation2.Germline MMR mutation- Lynch Syndrome
TT CCTT AA CC
A G C T GA G C T G
T C G A T C G A CCA G C T GA G C T G
TT CCTT AA CC
A G C T GA G C T G A G A G AA T GT G
T C T C TT A C A C
Microsatellite Instability (MSI)
Microsatellite Stable (MSS)
8
![Page 9: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/9.jpg)
Tumor MSI TestingNR21 BAT25 Mono27
Normal Tissue
Tumor Tissue
MSI-H: > 2/5 (30%) consensus MSI sequences
![Page 10: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/10.jpg)
MLH1 MSH2
Immunohistochemistry
![Page 11: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/11.jpg)
Multi Society Task Force Universal Testing of CRC for dMMR
11
Giardiello FM , Am J Gastro 2014;109:1159
![Page 12: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/12.jpg)
Universal Tumor Testing for LS• 1066 unselected tumors assessed for MSI/MMR
• 19.5% had MSI– 11% (21 patients) diagnosed with LS
• Phenotype:– 43% diagnosed > 50 years
– 22% did not Amsterdam II or revised Bethesda guidelines
Hampel H et al. NEJM 2005;352;18
Germline Testing Results In 21 Proband’s Relatives
Relationship Tested Positive Negative
First degree 54 25 29
Second degree 22 10 12
> Third degree 41 17 24
Total 117 52 65
![Page 13: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/13.jpg)
Typical Genetic Counseling Appointment
• Collect personal and family history
• Perform risk assessment (including breast cancer risk models)
• Educate about genetic syndromes, management options, genetic testing process
• Informed consent and coordination of genetic testing
• Psychosocial support and counseling
![Page 14: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/14.jpg)
Who Should Have Genetic Counseling for Lynch Syndrome?
• Abnormal MSI/IHC testing–(Unless MLH1 methylation is proven)
• Colon or endometrial cancer < 50
• > 2 Lynch Syndrome cancers in individual
• > 2 relatives with LS cancer, 1 < 50
• > 3 relatives with LS cancer at any age
![Page 15: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/15.jpg)
• > 10 colon adenomas
• Peutz-Jeghers Polyp
• Juvenile/Inflammatory Polyps
• Colon cancer < age 50
• Close relative diagnosed < age 50 or >2 close relatives with colon cancer
Who Should Have Genetic Counseling for other Colon Cancer Syndromes?
![Page 16: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/16.jpg)
Hereditary Colon Cancer SyndromesSyndrome Gene(s) Features
Lynch MLH1, MSH2, MSH6, PMS2, EPCAM
Colon, endometrial, ovarian, gastric, urinary tract, small bowel cancers, brain tumors, sebaceous neoplasms
Li Fraumeni TP53 Childhood cancers, sarcoma, leukemia, brain tumors, breast cancer, colon cancer
Familial Adenomatous Polyposis (FAP)
APC Adenomas, colon cancer, thyroid cancer, osteomas and soft tissue tumors, desmoid tumors
MYH-Associated Polyposis (MAP)
MUTYH* Adenomas, colon cancer, thyroid cancer
Peutz-Jeghers STK11 Mucocutaneous melanin spots, hamartomas, breast, GI, pancreatic, and rare gyn cancers
Cowden PTEN Hamartomas, derm lesions, macrocephaly, breast, thyroid, and endometrial cancers
Juvenile Polyposis Syndrome
BMPR1A, SMAD4
Hamartomas, colon cancer, some with SMAD4 have HHT
![Page 17: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/17.jpg)
HNPCC/Lynch syndrome!
colon ca 50
d. uterine ca 61
d. stroke 80
colon ca 47
57 6059 62
32 302427 35
d. colon ca 47
Traditional Cancer Risk Assessment and Genetic Testing
![Page 18: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/18.jpg)
Traditional Genetic Testing
• Utilizes Sanger sequencing and large rearrangement analysis
• Testing often limited to 1-2 syndromes based on assessment of personal/family history
• Only testing for high-risk, well known syndrome
• Variant of uncertain significance rate is low
• Results take 2-3 weeks
![Page 19: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/19.jpg)
Next Generation Sequencing
• Whole genome, or several genes can be analyzed at once
• Allows for testing many genes relatively inexpensively
• Used for panel genetic testing
– Cancer specific vs
– Pan cancer
![Page 20: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/20.jpg)
Multi-Gene Panels
• Benefits–Increased mutation
positive rate
–Identification of conditions of low clinical suspicion
–Cost effective
–Lower turn-around-time then reflex testing
• Limitations–Not all tests are
equal
–Various levels of gene coverage
–Increased VUS rate
–Moderate-risk genes
–Longer turn-around-time than single gene
![Page 21: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/21.jpg)
Insurance Coverage & Cost
• Most labs offer insurance pre-authorization
• Many labs billing with same CPT codes as BRCA, Lynch testing
• Costs range from $1500-$4400
![Page 22: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/22.jpg)
What Are Testing Options?
• 10 panels (5-28 genes)
• 10 panels (7-29 genes)–Build your own
• 7 panels (7-29 genes)–Build your own
• 1 panel (25 genes)
• 2 panels (20-52 genes)
![Page 23: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/23.jpg)
Example from Invitae
![Page 24: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/24.jpg)
Myriad Genetics Lab myRisk Gene Panel
![Page 25: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/25.jpg)
High Risk Genes
Breast Cancer
• BRCA1/BRCA2 (HBOC)
• CDH1 (Hereditary Diffuse Gastric Cancer)
• PTEN (Cowden)
• STK11 (Peutz-Jeghers)
• TP53 (Li-Fraumeni)
Colon Cancer
• APC (Familial Adenomatous Polyposis)
• BMPR1A/SMAD4 (Juvenile Polyposis)
• MLH1/MSH2/MSH6/PMS2/EPCAM (Lynch Syndrome)
• MYH (MYH-Associated Polyposis)
![Page 26: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/26.jpg)
High Risk Genes
• Significant risk of developing certain types of cancer
• Considerable research and professional society guidelines for screening and surgery
• Family members can be tested for the same mutation
![Page 27: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/27.jpg)
Moderate Risk Genes
• ATM (Ataxia Telangiectasia)
–Breast, pancreatic, colon
• CDKN2A (Familial Atypical Mole Malignant Melanoma)
–Pancreatic, melanoma
• CHEK2 (Li-Fraumeni Like Syndrome)
–Breast, prostate, colon
• PALB2 (Fanconi Anemia)
–Breast, pancreatic
![Page 28: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/28.jpg)
Moderate Risk Genes
• 2- to 4-fold risk over the general population risk.
• Cancer risk is not as elevated as a mutation in a high risk gene.
• Limited research and no professional society screening or surgical recommendations
• Family history is often better for risk stratification
• Unclear if it is beneficial to test other family members for these mutations
![Page 29: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/29.jpg)
Potential Results from myRisk
• Positive
–High risk gene
–Moderate risk gene
–New moderate risk gene
• Negative
• Variant of uncertain significance
![Page 30: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/30.jpg)
Incidental Finding Case 2
42dx br ca
42
45 34
64 6555 d. youngaccident
61 test ca
85dx female ca 65
90 d. 83dx br ca 60s
no info
Caucasian/N. American IrishAJ
n
![Page 31: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/31.jpg)
Lynch Syndrome PMS2
NCCN 2.2014
![Page 32: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/32.jpg)
2926
55 d.55 b/l br ca 44 BRCA -
47 50
8189CRC 89
88br ca 45
d. 64
Hungary Sicily
61 51
p
2
d. 40 Panc ca
d. 54 Panc ca
Incidental Finding Case 3
![Page 33: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/33.jpg)
Hereditary Diffuse Gastric Cancer
• CDH1 mutations
• 39% breast cancer risk by age 80
• Diffuse gastric cancer
– 67% for men and 83% for women by age 80
– Average onset 38 years (range of 14-69 years)
– Options for intense screening or prophylactic gastrectomy/mastectomy
![Page 34: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/34.jpg)
Variants of Uncertain Significance: Our results
• 235 VUS in 171 patients (41.4%)
– majority in moderate risk genes (62.2%)
• VUS rate lower in those of European ancestry than African, Asian, and Middle Eastern (p=0.001)
![Page 35: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/35.jpg)
Important Insurance Updates
• Companies requiring pre-test genetic counseling:
–CareSource
–CCF Employee Health Plan
–Cigna
–Medical Mutual of Ohio
![Page 36: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/36.jpg)
Conclusions
• Variety of “Genetic” tests to determine cause of hereditary colon cancer syndromes
• Currently, test the tumor first in patients with CRC
– Germline testing for polyposis or when tumor not available
• Genetic testing in transformation:
• NGS lowering costs and driving panel based testing
– Not all panel tests are created equal
• Caution: panel testing “easy” to order but complicated to interpret
• Get a lot of information we might not understand
• Find unanticipated mutations that highly impact patient care
![Page 37: Carol Burke, MD, FACG, FASGE, AGAF, FACP Sanford R Weiss Center for Hereditary Colorectal Neoplasia Department of Gastroenterology and Hepatology Cleveland.](https://reader030.fdocuments.us/reader030/viewer/2022032605/56649e835503460f94b85298/html5/thumbnails/37.jpg)